JP2002521490A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002521490A5 JP2002521490A5 JP2000562395A JP2000562395A JP2002521490A5 JP 2002521490 A5 JP2002521490 A5 JP 2002521490A5 JP 2000562395 A JP2000562395 A JP 2000562395A JP 2000562395 A JP2000562395 A JP 2000562395A JP 2002521490 A5 JP2002521490 A5 JP 2002521490A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- carrier
- drug
- base
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- 229940079593 drug Drugs 0.000 description 5
- 238000000034 method Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- 101800001690 Transmembrane protein gp41 Proteins 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000006215 rectal suppository Substances 0.000 description 1
- 229940100618 rectal suppository Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006216 vaginal suppository Substances 0.000 description 1
- 229940120293 vaginal suppository Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9467698P | 1998-07-30 | 1998-07-30 | |
| US60/094,676 | 1998-07-30 | ||
| US10026598P | 1998-09-14 | 1998-09-14 | |
| US60/100,265 | 1998-09-14 | ||
| US10105898P | 1998-09-18 | 1998-09-18 | |
| US60/101,058 | 1998-09-18 | ||
| US13229599P | 1999-05-03 | 1999-05-03 | |
| US60/132,295 | 1999-05-03 | ||
| PCT/US1999/017351 WO2000006599A1 (en) | 1998-07-30 | 1999-07-30 | Inhibitors of hiv membrane fusion |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010045882A Division JP2010180217A (ja) | 1998-07-30 | 2010-03-02 | Ｈｉｖ膜融合のインヒビター |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002521490A JP2002521490A (ja) | 2002-07-16 |
| JP2002521490A5 true JP2002521490A5 (enExample) | 2006-09-14 |
| JP5101764B2 JP5101764B2 (ja) | 2012-12-19 |
Family
ID=27492743
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000562395A Expired - Fee Related JP5101764B2 (ja) | 1998-07-30 | 1999-07-30 | Ｈｉｖ膜融合のインヒビター |
| JP2010045882A Pending JP2010180217A (ja) | 1998-07-30 | 2010-03-02 | Ｈｉｖ膜融合のインヒビター |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010045882A Pending JP2010180217A (ja) | 1998-07-30 | 2010-03-02 | Ｈｉｖ膜融合のインヒビター |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1100818B1 (enExample) |
| JP (2) | JP5101764B2 (enExample) |
| KR (1) | KR20010099605A (enExample) |
| AU (1) | AU770482B2 (enExample) |
| CA (1) | CA2338022C (enExample) |
| WO (1) | WO2000006599A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6841657B2 (en) | 1997-04-17 | 2005-01-11 | Whitehead Institute For Biomedical Research | Inhibitors of HIV membrane fusion |
| US6150088A (en) | 1997-04-17 | 2000-11-21 | Whitehead Institute For Biomedical Research | Core structure of gp41 from the HIV envelope glycoprotein |
| US6818740B1 (en) | 1997-04-17 | 2004-11-16 | Whitehead Institute For Biomedical Research | Inhibitors of HIV membrane fusion |
| US7960504B2 (en) | 1998-07-30 | 2011-06-14 | Whitehead Institute For Biomedical Research | Inhibitors of HIV membrane fusion |
| US6747126B1 (en) | 1998-07-30 | 2004-06-08 | Whitehead Institute For Biomedical Research | Peptide inhibitors of HIV entry |
| US7053179B2 (en) | 1999-12-16 | 2006-05-30 | Whitehead Institute For Biomedical Research | Five-Helix protein |
| AU2001233340B2 (en) | 2000-02-10 | 2006-05-04 | Panacos Pharmaceuticals, Inc. | Assay for detection of viral fusion inhibitors |
| US6664230B1 (en) * | 2000-08-24 | 2003-12-16 | The Regents Of The University Of California | Orally administered peptides to ameliorate atherosclerosis |
| US7199102B2 (en) | 2000-08-24 | 2007-04-03 | The Regents Of The University Of California | Orally administered peptides synergize statin activity |
| CA2423004C (en) * | 2000-09-22 | 2012-09-11 | Whitehead Institute For Biomedical Research | Peptide inhibitors of hiv entry |
| KR100447943B1 (ko) * | 2000-11-06 | 2004-09-08 | 한국과학기술연구원 | Ｈｉｖ의 감염 억제 펩타이드 |
| CN1100564C (zh) * | 2001-08-29 | 2003-02-05 | 周根发 | 用于治疗hiv感染的药物、其组合物及其用途 |
| CA2461853A1 (en) * | 2001-09-27 | 2003-04-03 | Tibotec Pharmaceuticals Ltd. | Anti-fusion assay |
| WO2003029284A1 (en) * | 2001-09-27 | 2003-04-10 | Nobutaka Fujii | Anti-hiv agent |
| EP1463521A4 (en) * | 2001-12-17 | 2009-06-24 | Us Gov Health & Human Serv | INHIBITOR OF GP41 |
| WO2005118886A2 (en) | 2004-06-01 | 2005-12-15 | Merck & Co., Inc. | Stable peptide mimetic of hiv gp41 fusion intermediate |
| RU2414236C2 (ru) | 2004-12-06 | 2011-03-20 | Зе Риджентс Оф Зи Юнивесити Оф Кэлифонье | Способ улучшения структуры и/или функций артериол |
| EP2005177B1 (en) * | 2006-04-06 | 2013-07-10 | Janssen R&D Ireland | A homogeneous time resolved fluorescence based test method |
| WO2013142298A1 (en) * | 2012-03-20 | 2013-09-26 | Merck Sharp & Dohme Corp. | Stable peptide mimetics of the hiv-1 gp41 pre-hairpin intermediate |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994002505A1 (en) * | 1992-07-20 | 1994-02-03 | Duke University | Compounds which inhibit hiv replication |
-
1999
- 1999-07-30 JP JP2000562395A patent/JP5101764B2/ja not_active Expired - Fee Related
- 1999-07-30 EP EP99937691A patent/EP1100818B1/en not_active Expired - Lifetime
- 1999-07-30 AU AU57886/01A patent/AU770482B2/en not_active Ceased
- 1999-07-30 KR KR1020017001273A patent/KR20010099605A/ko not_active Ceased
- 1999-07-30 CA CA2338022A patent/CA2338022C/en not_active Expired - Fee Related
- 1999-07-30 WO PCT/US1999/017351 patent/WO2000006599A1/en not_active Ceased
-
2010
- 2010-03-02 JP JP2010045882A patent/JP2010180217A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002521490A5 (enExample) | ||
| AU725283B2 (en) | Bioadhesive pharmaceutical composition for the controlled release of active principles | |
| CA2293346A1 (en) | Device and method for treatment of dysmenorrhea | |
| NO20051964D0 (no) | Terapeutiske blandinger for legemiddelavlevering til og gjennom dekkende epitel | |
| DE3650189D1 (de) | Mittel zur nichsystemischen Verabreichung von Sedativa und Analgetika. | |
| ES2249763T5 (es) | Sistema de administracion transdermica de farmaco potente de flujo bajo. | |
| JP2005517669A5 (enExample) | ||
| JP2003505345A5 (enExample) | ||
| JP2009261939A (ja) | 安全性が改善されたコンドーム | |
| NO20014859D0 (no) | Raskt dispergerbare doseringsformer inneholdende fiskegelatin | |
| BR9808888A (pt) | Formas de dosagem e método de melhorar disfunção erétil masculina | |
| JP2007525461A5 (enExample) | ||
| EP1768625A2 (en) | Sustained release compositions containing progesterone receptor modulators | |
| CO5680109A1 (es) | Compuestos para el tratamiento de la disfuncion sexual femenina | |
| HUP9802913A2 (hu) | Bioadhezív, szilárd gyógyszer-adagolási forma | |
| JP2000026284A (ja) | 経皮ドラッグデリバリ―のための固体マトリックスシステム | |
| NO20043871L (no) | Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid | |
| EP0280737A4 (en) | Steroidal drug-containing preparation for external use. | |
| BR0007360A (pt) | Composição de liberação controlada | |
| HRP20040479B1 (en) | Vaginally administered anti-dysrhythmic agents for treating pelvic pain and infertility | |
| EP0873751A3 (en) | Pharmaceutical product for application to uterus mucosa | |
| AR242109A1 (es) | Dispositivo para fijar un dispositivo contraceptivo a la pared del utero, particularmente en el periodo inmediatamente posterior al parto. | |
| NZ509031A (en) | A disk formed from a filmogenic polymer carrying a therapeutic agent selected from a stabiliser, a solubiliser, an enhancer and a plasticiser | |
| JP2003511403A5 (enExample) | ||
| ATE326199T1 (de) | Vorrichtung zur gleichzeitigen austragung von wirkstoffen in den cervikal- und vaginalkanal |